{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:35:56Z","timestamp":1780551356728,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.bmc.2017.01.016","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T03:15:40Z","timestamp":1484363740000},"page":"1524-1532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity"],"prefix":"10.1016","volume":"25","author":[{"given":"Georgios","family":"Paraskevopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Vos\u00e1tka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kr\u00e1tk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Navr\u00e1tilov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franti\u0161ek","family":"Trejtnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159ina","family":"Stola\u0159\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmila","family":"Vin\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.01.016_b0005","unstructured":"Global tuberculosis report. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf?ua=1>; 2015 Accessed 3.10.2016."},{"key":"10.1016\/j.bmc.2017.01.016_b0010","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","article-title":"Global epidemiology of tuberculosis","volume":"367","author":"Dye","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2017.01.016_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(07)61043-5","article-title":"Anti-TNFalpha treatment and reactivation of latent tuberculosis","volume":"370","author":"Jolobe","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2017.01.016_b0020","first-page":"857","article-title":"Treatment of tuberculosis: present status and future prospects","volume":"83","author":"Onyebujoh","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.bmc.2017.01.016_b0025","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/AAC.43.12.2922","article-title":"High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection","volume":"43","author":"Cynamon","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.01.016_b0030","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jac\/46.4.571","article-title":"Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex","volume":"46","author":"Bemer-Melchior","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2017.01.016_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1574-695X.2008.00400.x","article-title":"Extensively drug-resistant tuberculosis: current challenges and threats","volume":"53","author":"Jain","year":"2008","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.bmc.2017.01.016_b0040","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/joim.12264","article-title":"Totally drug-resistant tuberculosis and adjunct therapies","volume":"277","author":"Parida","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/j.bmc.2017.01.016_b0045","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1016\/S1473-3099(16)00070-0","article-title":"Tuberculosis\u2013advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers","volume":"16","author":"Wallis","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2017.01.016_b0050","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1021\/jm9803572","article-title":"Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria","volume":"41","author":"Macielag","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjp.0706873","article-title":"Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening","volume":"149","author":"De La Fuente","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2017.01.016_b0060","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bmcl.2008.11.080","article-title":"Salicylanilide esters of N-protected amino acids as novel antimicrobial agents","volume":"19","author":"Imramovsk\u00fd","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.01.016_b0065","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.bmc.2013.12.016","article-title":"Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity","volume":"22","author":"Vin\u0161ov\u00e1","year":"2014","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0070","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1016\/j.bmc.2013.08.029","article-title":"New derivatives of salicylamides: preparation and antimicrobial activity against various bacterial species","volume":"21","author":"Pauk","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bmc.2012.10.056","article-title":"Structure-activity relationships of antitubercular salicylanilides consistent with disruption of the proton gradient via proton shuttling","volume":"21","author":"Lee","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tube.2012.06.001","article-title":"Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase","volume":"92","author":"Kr\u00e1tk\u00fd","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.bmc.2017.01.016_b0085","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1016\/j.bmc.2010.10.036","article-title":"High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase","volume":"18","author":"Cheng","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.bmcl.2007.10.051","article-title":"Identification of novel inhibitors of bacterial surface enzyme Staphylococcus aureus Sortase A","volume":"18","author":"Chenna","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.01.016_b0095","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bmc.2008.02.046","article-title":"ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffolds","volume":"17","author":"Triola","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0100","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.2174\/138161211798194521","article-title":"Salicylanilide ester prodrugs as potential antimicrobial agents \u2013 a review","volume":"17","author":"Kr\u00e1tk\u00fd","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bmc.2017.01.016_b0105","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bmc.2014.12.019","article-title":"Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates","volume":"23","author":"Kr\u00e1tk\u00fd","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ardp.200390004","article-title":"Relationship between the structure and antimycobacterial activity of substituted salicylanilides","volume":"336","author":"Waisser","year":"2003","journal-title":"Arch Pharm (Weinheim)"},{"key":"10.1016\/j.bmc.2017.01.016_b0115","first-page":"121","article-title":"Synthesis and antimycobacterial activity of salicylanilides substituted in position 5","volume":"55","author":"Waisser","year":"2001","journal-title":"Chem Pap"},{"key":"10.1016\/j.bmc.2017.01.016_b0120","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.1016\/j.bmc.2015.10.029","article-title":"Novel derivatives of nitro-substituted salicylic acids: synthesis, antimicrobial activity and cytotoxicity","volume":"23","author":"Paraskevopoulos","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0125","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1016\/j.ejmech.2010.09.040","article-title":"New amino acid esters of salicylanilides active against MDR-TB and other microbes","volume":"45","author":"Kr\u00e1tk\u00fd","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2017.01.016_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2013.12.001","article-title":"Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase","volume":"53","author":"Kr\u00e1tk\u00fd","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2017.01.016_b0135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrgastro.2010.134","article-title":"Hepatotoxic effects of therapies for tuberculosis","volume":"7","author":"Senousy","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bmc.2017.01.016_b0140","first-page":"2826","article-title":"Reductive dechlorination of chloro-phenols and -benzoic acids by Raney Co-Al alloy in an alkaline deuterium oxide solution and preparation of deuterated salicylic acids","author":"Tashiro","year":"1989","journal-title":"J Chem Res (M)"},{"key":"10.1016\/j.bmc.2017.01.016_b0145","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.bmcl.2013.01.055","article-title":"Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors","volume":"23","author":"Kang","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2017.01.016_b0150","first-page":"115","article-title":"Quantitative micromethod for susceptibility testing of mycobacteria in \u0160ula's medium","volume":"3","author":"Kaustov\u00e1","year":"1997","journal-title":"J Klin Microbiol Inf L\u00e9k"}],"updated-by":[{"DOI":"10.1016\/j.bmc.2017.02.053","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,4,15]],"date-time":"2017-04-15T00:00:00Z","timestamp":1492214400000}}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089616308823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089616308823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:48:58Z","timestamp":1760834938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089616308823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0968089616308823"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.01.016","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}